634 search results for “hybrid drug” in the Student website
-
Major study offers practical guidance on antibiotic dosing in patients with obesity
Leiden researcher Anne-Grete Märtson brought together a large number of studies to better understand antibiotic dosing in patients with obesity. The publication in a renowned medical journal has already garnered much positive reactions, Märtson says. ‘It’s high time researchers started sharing more…
-
Over a million euros for two studies on solutions to antimicrobial resistance
Two consortia led by Leiden researchers have been awarded over one million euros by the Dutch Research Council and the Ministry of Health, Welfare and Sport to find solutions to antimicrobial resistance.
-
Leiden scientists join national effort to advance nanomedicine
A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.
-
Roxanne Kieltykar.e.kieltyka@chem.leidenuniv.nl | 071 5274441
-
How Oncode-PACT is bringing new cancer medicines closer with 325 million in Growth Fund money
How can you ensure that more experimental drugs reach the finish line? At the moment, only one in twenty cancer drugs that are tested on humans makes it to the market. This is an enormous loss for patients and society. With a grant from the National Growth Fund, Oncode-PACT aims to efficiently select…
-
Serkan Aslans.aslan@lacdr.leidenuniv.nl | 071 5275919
-
Seeking new concepts to treat diseases
Scientific Director of the Leiden Academic Centre for Drug Research (LACDR) Hubertus Irth: ‘We test substances and look for new concepts for treating disease.’
-
Sebastian Pompluns.j.pomplun@lacdr.leidenuniv.nl | 071 5274651
-
Coen van Hasseltcoen.vanhasselt@lacdr.leidenuniv.nl | 071 5273266
-
Anthe Janssena.p.a.janssen@lic.leidenuniv.nl | 071 5272727
-
Leiden ‘super antibiotic’ keeps dangerous gut bacterium under control with a low dose
The antibiotic EVG7, developed in Leiden, has proven capable of fighting the dangerous gut bacterium C. difficile with only a minimal dose. What’s more, the bacterium is far less likely to return, a major issue with existing antibiotics. The research was published in Nature Communications.
-
‘Never stop trying’: Barz sees his polymers enter clinical trials
A new class of polymers has been used in patients for the first time. The compound is the first new drug solubilising agent in decades. Introduced in 2014 by chemist Matthias Barz from Leiden University, it offers a unique alternative to current options.
-
Thomas Hankemeierhankemeier@lacdr.leidenuniv.nl | 071 5274226
-
Agreements
Read here about the various agreements in place at Leiden University for student and study associations and other student organisations.
-
During the next pandemic, this mathematical model will speed up the search for treatment
Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
Olivier Béquignono.j.m.bequignon@lacdr.leidenuniv.nl | 071 5272727
-
CANCELLED: Gloves are off: When and why allies use cyber weapons in hybrid scenarios?
Lecture
-
Daisy Batenburgd.batenburg@lacdr.leidenuniv.nl | 071 5272727
-
Kim Elbertsek.elbertse@lacdr.leidenuniv.nl | 071 5272727
-
Elsa Neuberte.neubert@lacdr.leidenuniv.nl | 071 5272727
-
Andraniek Evadgian -
Madouc Bergers made her own enzyme inhibitors for her bachelor’s thesis
For her bachelor’s thesis, Molecular Science and Technology student Madouc Bergers synthesized her own molecule that can inhibit the breakdown of sugars. Although most students do not even manage to make one building block, Madouc made three. Partly because of this, she has been nominated for the Science…
-
Myrtille Koerselmanm.e.koerselman@lacdr.leidenuniv.nl | 071 5276270
-
Kostas Tassisk.tassis@lacdr.leidenuniv.nl | 071 5276302
-
Leo Pricelsprice@lacdr.leidenuniv.nl | 071 5272727
-
Marc Boefm.a.boef@lacdr.leidenuniv.nl | 071 5272727
-
Nada Badrn.badr@lacdr.leidenuniv.nl | 071 5272727
-
Bola Khalilb.a.a.khalil@lacdr.leidenuniv.nl | 071 5272727
-
Matthijs Vlasveldm.p.vlasveld@lacdr.leidenuniv.nl | 071 5272727
-
Linde Schoenmakerl.schoenmaker@lacdr.leidenuniv.nl | 071 5274607
-
Daan Jiskootd.a.jiskoot@lacdr.leidenuniv.nl | 071 5272727
-
Chiel Jespersm.jespers@lacdr.leidenuniv.nl | 071 5272727
-
Rosan Kuinr.c.m.kuin@lacdr.leidenuniv.nl | 071 5272727
-
Nasi Liun.s.liu@lacdr.leidenuniv.nl | 071 5276225
-
Mark Fonteynem.fonteyne@lacdr.leidenuniv.nl | 071 5272727
-
Martijn Moném.j.mone@lacdr.leidenuniv.nl | 071 5276105
-
Martin Sichom.sicho@lacdr.leidenuniv.nl | 071 5274206
-
Annaloes Fokkelman-Klipj.e.fokkelman@lacdr.leidenuniv.nl | 071 5274496
-
Kirsten Veltmanc.h.j.veltman@lacdr.leidenuniv.nl | 071 5272727
-
Xiaobing Zhangx.zhang@lacdr.leidenuniv.nl | 071 5272727
-
Lukas Wijayal.s.wijaya@lacdr.leidenuniv.nl | 071 5275706
-
Sabine de Winters.de.winter@lacdr.leidenuniv.nl | 071 5272727
-
Linglu Xul.xu@lacdr.leidenuniv.nl | 071 5276039
-
Britt Duijndamb.h.a.duijndam@lacdr.leidenuniv.nl | 071 5272727
-
Lucy Sinkel.j.sinke@lacdr.leidenuniv.nl | 071 5276039
-
Mick van Schaickm.van.schaick@lacdr.leidenuniv.nl | 071 5272727
-
Gerard Mulderg.mulder@lacdr.leidenuniv.nl |
-
Arnoud Sonnenberga.sonnenberg@nki.nl | 071 5272727
-
Natasha Tahirn.tahir@lacdr.leidenuniv.nl | 071 5275919